These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 22006235)

  • 1. Effects of botulinum toxin a on cytokine synthesis in a cell culture model of cutaneous scarring.
    Haubner F; Ohmann E; Müller-Vogt U; Kummer P; Strutz J; Gassner HG
    Arch Facial Plast Surg; 2012; 14(2):122-6. PubMed ID: 22006235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of botulinum toxin A on patient-specific keloid fibroblasts in vitro.
    Haubner F; Leyh M; Ohmann E; Sadick H; Gassner HG
    Laryngoscope; 2014 Jun; 124(6):1344-51. PubMed ID: 24122729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin type a inhibits connective tissue growth factor expression in fibroblasts derived from hypertrophic scar.
    Xiao Z; Zhang M; Liu Y; Ren L
    Aesthetic Plast Surg; 2011 Oct; 35(5):802-7. PubMed ID: 21455826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of botulinum toxin type A on transforming growth factor beta1 in fibroblasts derived from hypertrophic scar: a preliminary report.
    Xiao Z; Zhang F; Lin W; Zhang M; Liu Y
    Aesthetic Plast Surg; 2010 Aug; 34(4):424-7. PubMed ID: 19802513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Botulinum Toxin Type A on Differentiation of Fibroblasts Derived from Scar Tissue.
    Jeong HS; Lee BH; Sung HM; Park SY; Ahn DK; Jung MS; Suh IS
    Plast Reconstr Surg; 2015 Aug; 136(2):171e-178e. PubMed ID: 26218391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin type A suppresses pro-fibrotic effects via the JNK signaling pathway in hypertrophic scar fibroblasts.
    Park GS; An MK; Yoon JH; Park SS; Koh SH; Mauro TM; Cho EB; Park EJ; Kim KH; Kim KJ
    Arch Dermatol Res; 2019 Dec; 311(10):807-814. PubMed ID: 31501922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and possible mechanisms of Botulinum Toxin type A on hypertrophic scarring.
    Hao R; Li Z; Chen X; Ye W
    J Cosmet Dermatol; 2018 Jun; 17(3):340-346. PubMed ID: 29569821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a near-senescent human dermal fibroblast cell line and effect of amelogenin.
    Almqvist S; Werthén M; Johansson A; Törnqvist J; Agren MS; Thomsen P
    Br J Dermatol; 2009 Jun; 160(6):1163-71. PubMed ID: 19298284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of fibroblast activation protein-alpha in keloid fibroblasts: implications for development of a novel treatment option.
    Dienus K; Bayat A; Gilmore BF; Seifert O
    Arch Dermatol Res; 2010 Dec; 302(10):725-31. PubMed ID: 20872224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential effect of botulinum toxin type A on human dermal fibroblasts: an in vitro study.
    Oh SH; Lee Y; Seo YJ; Lee JH; Yang JD; Chung HY; Cho BC
    Dermatol Surg; 2012 Oct; 38(10):1689-94. PubMed ID: 22742715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cadexomer as well as cadexomer iodine induces the production of proinflammatory cytokines and vascular endothelial growth factor by human macrophages.
    Ohtani T; Mizuashi M; Ito Y; Aiba S
    Exp Dermatol; 2007 Apr; 16(4):318-23. PubMed ID: 17359338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial-mesenchymal interactions in keloid pathogenesis modulate vascular endothelial growth factor expression and secretion.
    Ong CT; Khoo YT; Tan EK; Mukhopadhyay A; Do DV; Han HC; Lim IJ; Phan TT
    J Pathol; 2007 Jan; 211(1):95-108. PubMed ID: 17136757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of fibroblasts and fibroblast-derived factors in periprosthetic osteolysis.
    Koreny T; Tunyogi-Csapó M; Gál I; Vermes C; Jacobs JJ; Glant TT
    Arthritis Rheum; 2006 Oct; 54(10):3221-32. PubMed ID: 17009257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-molecular-weight hyaluronan inhibits macrophage proliferation and cytokine release in the early wound of a preclinical postlaminectomy rat model.
    Schimizzi AL; Massie JB; Murphy M; Perry A; Kim CW; Garfin SR; Akeson WH
    Spine J; 2006; 6(5):550-6. PubMed ID: 16934726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Research advances on application of botulinum toxin type A in scar prevention and treatment].
    Yu Z; Ren P; Zhang H; Chen H; Ma FX
    Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2022 Apr; 38(4):385-388. PubMed ID: 35462519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of botulinum toxin type A injection on hypertrophic scar in rabbit ear model].
    Wang L; Tai NZ; Fan ZH
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2009 Jul; 25(4):284-7. PubMed ID: 19873722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum Toxin Type A Inhibits α-Smooth Muscle Actin and Myosin II Expression in Fibroblasts Derived From Scar Contracture.
    Chen M; Yan T; Ma K; Lai L; Liu C; Liang L; Fu X
    Ann Plast Surg; 2016 Sep; 77(3):e46-9. PubMed ID: 25144422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin to minimize facial scarring.
    Jablonka EM; Sherris DA; Gassner HG
    Facial Plast Surg; 2012 Oct; 28(5):525-35. PubMed ID: 23027220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor-C promotes vasculogenesis, angiogenesis, and collagen constriction in three-dimensional collagen gels.
    Bauer SM; Bauer RJ; Liu ZJ; Chen H; Goldstein L; Velazquez OC
    J Vasc Surg; 2005 Apr; 41(4):699-707. PubMed ID: 15874936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differing responses of human follicular and nonfollicular scalp cells in an in vitro wound healing assay: effects of estrogen on vascular endothelial growth factor secretion.
    Stevenson S; Taylor AH; Meskiri A; Sharpe DT; Thornton MJ
    Wound Repair Regen; 2008; 16(2):243-53. PubMed ID: 18318810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.